Aphria stock analysis

    • [PDF File]2015 - Aphria

      https://info.5y1.org/aphria-stock-analysis_1_6fafbb.html

      Discussion & Analysis This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Aphria Inc., (the “Company” or “Aphria”), is for the year ended May 31, 2015. It is supplemental to, and should be read in conjunction with the Company’s consolidated financial statements and the accompanying

      aphria stock price target


    • [PDF File]APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS …

      https://info.5y1.org/aphria-stock-analysis_1_44befd.html

      APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS Page 1 APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Aphria Inc., (the “Company” or “Aphria”), is for

      aphria stock news


    • [PDF File]APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS

      https://info.5y1.org/aphria-stock-analysis_1_f240a1.html

      APHRIA INC. MANAGEMENT’S DISCUSSION & ANALYSIS Page ½2 The Company is focused on producing and selling medical marijuana and its derivatives through a two-pronged growth strategy, including both retail sales and wholesale channels. Retail sales are primarily sold through Aphria’s online store as well as telephone orders.

      aphria stock price


    • [PDF File]CLASS ACTION COMPLAINT FOR VIOLATIONS OF THE …

      https://info.5y1.org/aphria-stock-analysis_1_ec3954.html

      Aphria’s common stock trades on the Toronto Stock Exchange under the symbol “APH.” In the US, Aphria’s common stock traded over-the-counter on the OTCQB Venture Market exchange under the symbol “APHQF” until November 2, 2018, when it began trading on the New York Stock Exchange (“NYSE”) under the symbol “APHA.” 15.

      aphria news


    • [PDF File]RESEARCH REPORT | January 10, 2019 Aphria Inc.

      https://info.5y1.org/aphria-stock-analysis_1_8f4a15.html

      Aphria Inc. (APHA-T, APHA-NYSE) SECTOR: Special Situations CATALYSTS 1. January 11, 2019 – Fiscal Q2/19 financial results released 2. Near Term – Response from independent committee of the BoD with respect to the short-report 3. On-going – Potential M&A and partnerships STOCK PRICE $8.92 RATING BUY TARGET PRICE $13.00 SCENARIO ANALYSIS

      aphria stock price nasdaq


    • MARCH 2019 Targeted Behavioural Bias Emotional Cascade ...

      Emotional Cascade trade – Aphria Aphria had been underperforming the Canadian healthcare sector during the market correction in the fourth quarter of 2018. Prices then fell off the cliff following a report issued by Quintessential Capital and Hindenburg Research on December 3 which recommended short-selling the stock.

      aphria message board


Nearby & related entries: